UBS analyst Ashwani Verma raised the price target on Alkermes (NASDAQ: ALKS) to $47.00 (from $46.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE